Next we tested if the lung cancer patient-derived-xenograft-derived cell line LPC43, which expresses a much higher level of endogenous SHMT2 compared with HeLa (see Fig 1B) was sensitive to glycine deprivation as a function of SHMT2 expression. Here, SHMT2 is linked to lung carcinoma.